Chromomycosis. Treatment with a combination of thiabendazole and 5-fluorocytosine, 6-year follow-up
Solano, E.; Hidalgo, H.; Castro, A.; Montero-Gei, F.
Medicina Cutanea Ibero-Latino-Americana 11(6): 413-418
1983
ISSN/ISBN: 0210-5187 PMID: 6366398 Document Number: 210529
The results of the treatment of 30 cases of chromomycosis (fonsecal pedrosoi) with Thiabendazole (1 g.) and 5. Fluorocytosine (4 g.) are reported. The medium rate of healing was 7,63 months. This treatment was effective in 25 of 30 cases (83 por 100) and ono-effective in 3 (10 por 100). In 2 cases recurrences occurred (6,66 por 100).
Document emailed within 1 workday
Related Documents
Lopes, C.F.; Resende, M.A.; Alvarenga, R.J.; Moreira, Y.K. 1979: Combination of 5-fluorocytosine and amphotericin B in the treatment of chromomycosis Medicina Cutanea Ibero-Latino-Americana 7(1-3): 1-7Bayles, M.A. 1971: Chromomycosis. Treatment with thiabendazole Archives of Dermatology 104(5): 476-485
Gentilini, M.; Danis, M.; Dürr, J.M.; Garabiol, B. 1971: Treatment of ancylostomiasis with a combination of thiabendazole-levamisole (200 ccases) Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 64(6): 891-900
Desakorn, V.; Karmacharya, B.Man.; Thanachartwet, V.; Kyaw, N.Lin.; Tansuphaswadikul, S.; Sahassananda, D.; Dhitavat, J.; Maek-a-nantawat, W.; Pitisuttithum, P. 2011: Effectiveness of fixed-dose combination stavudine, lamivudine and nevirapine (GPO-VIR) for treatment of naïve HIV patients in Thailand: a 3-year follow-up Southeast Asian Journal of Tropical Medicine and Public Health 42(6): 1414-1422
Beggs, W.H.; Sarosi, G.A.; Andrews, F.A. 1974: Inhibition of Candida albicans by amphotericin B in combination with 5-fluorocytosine Research Communications in Chemical Pathology and Pharmacology 8(3): 559-562
Lhermitte, F.; Marteau, R.; de Saxcé, H. 1987: Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up Revue Neurologique (Paris) 143(2): 98-107
Stuart, J.E.; Welch, J.S. 1973: Trial of thiabendazole and viprynium embonate in combination for trichuriasis in aboriginal children Medical Journal of Australia 2(22): 1017-1019
Bregani, E.R.; Tantardini, F.; Rovellini, A. 2007: Case report: effects of diethylcarbamazine and thiabendazole combination against Mansonella perstans filariasis Parassitologia 49(1-2): 37-38
DeRosanda, M.A. 1979: Susceptibility tests of Fonsecaea pedrosoi strains to the combination of thiabendazole and amphotericin B "in vitro" Revista do Instituto de Medicina Tropical de Sao Paulo 21(6): 347-349
Baumann, A.; Stieber, J.; Löwel, H. 1997: Nonparticipation as a factor influencing the value of follow-up studies. Results of a telephone 5-year follow-up interview of 55-74-year-old participants of the Augsburg 1989/90 MONICA Survey Gesundheitswesen ) 59 Suppl. 1: 19-25
Cornwell, R.L.; Jones, R.M.; Pott, J.M. 1971: The control of parasitism in fat lamb production by routine dosing with tetramisole, thiabendazole and a morantel-diethylcarbamazine combination Veterinary Record 89(25): 659-662
Mahapatra, D.; Mahapatra, R.K.; Yaden, S.; Hunter, K.W. 1986: Acute titration and chronic follow-up with captopril in hypertension. a one-year safety profile on combination therapy with captopril and a diuretic Angiology 37(12 Part 1): 865-879
Van Onna, M.; van Tubergen, A.; van der Heijde, D.; Jurik, A.G.; Landewé, R. 2014: Gadolinium contrast-enhanced MRi sequence does not have an incremental value in the assessment of sacroiliitis in patients with early inflammatory back pain by using MRi in combination with pelvic radiographs: a 2-year follow-up study Clinical and Experimental Rheumatology 32(2): 225-230
Koszewski, W.; Bacia, T.; Rysz, A. 2003: Vagus nerve stimulation (VNS) in the treatment of drug-resistant epilepsy. a 4-year follow-up evaluation of VNS treatment efficacy Neurologia i Neurochirurgia Polska 37(3): 573-586
Stanton, K.G.; Sanderson, C.R. 1974: The treatment of systemic cryptococcosis with 5-fluorocytosine Australian and New Zealand Journal of Medicine 4(3): 262-266
Hsi, M.S.; Chen, R.C.; Hung, T.P. 1975: Treatment of cryptococcal meningitis with 5-fluorocytosine. Report of 2 cases Journal of the Formosan Medical Association 74(2): 129-136
Shibru Berhanu; Prevett, M. 2004: Treatment of epilepsy in rural Ethiopia: 2 year follow-up Ethiopian Journal of Health Development 18(1): 31-34
Berlin, E.; Gjöres, J.E.; Ivarsson, C.; Palmqvist, I.; Thagg, G.; Thulesius, O. 1999: Postmastectomy lymphoedema. Treatment and a five-year follow-up study International Angiology: a Journal of the International Union of Angiology 18(4): 294-298
Rault, R.M.; Hulme, B.; Davies, R.R. 1975: 5-Fluorocytosine treatment of candidiasis on a patient receiving regular hemodialysis Clinical Nephrology 3(6): 225-227
Pollack, M.H.; Tesar, G.E.; Rosenbaum, J.F.; Spier, S.A. 1986: Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up Journal of Clinical Psychopharmacology 6(5): 302-304